What is Iotamotion?
Iotamotion is at the forefront of medical device innovation, focusing on cochlear implant insertion technology. Their flagship product, the iotaSOFT Insertion System, leverages robotic assistance to ensure precise and gentle insertion of electrodes, thereby minimizing trauma to the cochlea. This technology aims to improve surgical success rates and expand access to cochlear implants for individuals suffering from severe hearing loss. The company's mission is to overcome common surgical barriers and provide advanced solutions to surgeons, hospitals, and patients.
How much funding has Iotamotion raised?
Iotamotion has raised a total of $18.4M across 4 funding rounds:
Angel/Seed
$2M
Angel/Seed
$2.5M
Series A
$12M
Debt
$1.9M
Angel/Seed (2017): $2M with participation from Undisclosed
Angel/Seed (2019): $2.5M led by Undisclosed
Series A (2023): $12M supported by Mutual Capital Partners, ISA Ventures, and Next Level Ventures
Debt (2026): $1.9M, investors not publicly disclosed
Key Investors in Iotamotion
Mutual Capital Partners
Mutual Capital Partners is a venture capital firm based in Cleveland that invests in early-stage software and medical device companies, particularly in the Midwest. They provide financial support and strategic guidance to healthcare startups.
ISA Ventures
ISA Ventures is Iowa's first multi-stage venture capital fund, supporting Iowa-based companies in sectors like biotechnology and healthcare. They provide capital ranging from $25k to $1 million for early-revenue to expansion-stage businesses.
Next Level Ventures
Next Level Ventures is an Iowa-based investment firm managing over $400 million, specializing in strategic investments from seed to growth stages, with a focus on fintech and supporting portfolio companies operationally.
What's next for Iotamotion?
With the recent Series A financing and a history of strategic investments, Iotamotion is well-positioned for accelerated growth and market penetration. The company's focus on enhancing surgical precision and patient outcomes in the cochlear implant sector aligns with the increasing demand for advanced medical technologies. Future endeavors will likely involve scaling production, expanding clinical adoption, and further research and development to refine their innovative insertion system. The backing from specialized venture capital firms suggests a strong belief in the company's potential to disrupt the hearing loss treatment market and achieve significant commercial success.
See full Iotamotion company page
